275 related articles for article (PubMed ID: 28501127)
41. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
42. Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning.
Zhou C; Wang Y; Ji MH; Tong J; Yang JJ; Xia H
Cancer Control; 2020; 27(1):1073274820968900. PubMed ID: 33115287
[TBL] [Abstract][Full Text] [Related]
43. Analysis of surgery for incurable gastric cancer.
Zhao H; Chen W; Lin Y; Qin J; Wang L
World J Surg Oncol; 2015 Dec; 13():339. PubMed ID: 26684015
[TBL] [Abstract][Full Text] [Related]
44. A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients.
Zheng Z; Zhang Y; Zhang L; Li Z; Wu X; Liu Y; Bu Z; Ji J
BMC Cancer; 2016 Feb; 16():92. PubMed ID: 26873736
[TBL] [Abstract][Full Text] [Related]
45. Peritoneal carcinoembryonic antigen level for predicting locoregional and distant spread of gastric cancer.
Cetin B; Atalay C; Aslan S; Babacan B; Hatipoğlu C; Akinci M; Cetin A
Surg Today; 2005; 35(11):919-24. PubMed ID: 16249844
[TBL] [Abstract][Full Text] [Related]
46. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
47. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
48. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
[TBL] [Abstract][Full Text] [Related]
49. Prediction of Peritoneal Recurrence in Patients with Gastric Cancer: a Multicenter Study.
Kus T; Kose F; Aktas G; Arslan UY; Sedef AM; Cinkir HY; Dirikoc M; Akkus G; Ozdemir NY
J Gastrointest Cancer; 2021 Jun; 52(2):634-642. PubMed ID: 32578034
[TBL] [Abstract][Full Text] [Related]
50. Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma.
Nakata B; Hirakawa-YS Chung K; Kato Y; Yamashita Y; Maeda K; Onoda N; Sawada T; Sowa M
Cancer; 1998 Dec; 83(12):2488-92. PubMed ID: 9874453
[TBL] [Abstract][Full Text] [Related]
51. Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancer.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Miyagi Y
Gastric Cancer; 2006; 9(2):106-13. PubMed ID: 16767366
[TBL] [Abstract][Full Text] [Related]
52. Patterns, timing and risk factors of recurrence of gastric cancer after laparoscopic gastrectomy: reliable results following long-term follow-up.
Nakagawa M; Kojima K; Inokuchi M; Kato K; Sugita H; Kawano T; Sugihara K
Eur J Surg Oncol; 2014 Oct; 40(10):1376-82. PubMed ID: 24915857
[TBL] [Abstract][Full Text] [Related]
53. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
[TBL] [Abstract][Full Text] [Related]
54. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
55. Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time.
Zhou M; Bracci PM; McCoy LS; Hsuang G; Wiemels JL; Rice T; Zheng S; Kelsey KT; Wrensch MR; Wiencke JK
Int J Cancer; 2015 Aug; 137(4):826-36. PubMed ID: 25604093
[TBL] [Abstract][Full Text] [Related]
56. Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients.
Kitamura M; Toi M; Arai K; Iwasaki Y; Suzuki H; Matsuo K
Oncol Rep; 1998; 5(6):1419-24. PubMed ID: 9769380
[TBL] [Abstract][Full Text] [Related]
57. Surgery-induced peritoneal cancer cells in patients who have undergone curative gastrectomy for gastric cancer.
Takebayashi K; Murata S; Yamamoto H; Ishida M; Yamaguchi T; Kojima M; Shimizu T; Shiomi H; Sonoda H; Naka S; Mekata E; Okabe H; Tani T
Ann Surg Oncol; 2014 Jun; 21(6):1991-7. PubMed ID: 24499832
[TBL] [Abstract][Full Text] [Related]
58. Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma.
Wang G; Yu D; Tan W; Zhao D; Wu C; Lin D
Cancer; 2009 Jun; 115(11):2430-7. PubMed ID: 19298002
[TBL] [Abstract][Full Text] [Related]
59. REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma.
Moon JH; Fujiwara Y; Nakamura Y; Okada K; Hanada H; Sakakura C; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
J Surg Oncol; 2012 Feb; 105(2):189-94. PubMed ID: 21780125
[TBL] [Abstract][Full Text] [Related]
60. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
